ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,273.08
0.18%
Dow Jones
44,860.31
0.28%
Gold vs US Dollar
2,649.485
0.65%
Brent Oil
72.71
0.36%
Bitcoin
93,153.79
1.28%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Voyager Therapeutics Inc (VYGR)

  7. Voyager Therapeutics Inc (VYGR) News

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VYGR
DateTimeSourceHeadlineSymbolCompany
20/11/202412:00GlobeNewswire Inc.Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s DiseaseNASDAQ:VYGRVoyager Therapeutics Inc
12/11/202421:01GlobeNewswire Inc.Voyager Reports Third Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
12/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
06/11/202412:00GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
05/11/202412:00GlobeNewswire Inc.Voyager Therapeutics Announces Third Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
03/10/202420:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/10/202420:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
02/10/202420:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
16/09/202411:00GlobeNewswire Inc.Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate SelectedNASDAQ:VYGRVoyager Therapeutics Inc
05/09/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
05/09/202412:00GlobeNewswire Inc.Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14NASDAQ:VYGRVoyager Therapeutics Inc
29/08/202420:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
29/08/202411:00GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
07/08/202411:00GlobeNewswire Inc.Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company ShowcaseNASDAQ:VYGRVoyager Therapeutics Inc
06/08/202420:11Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYGRVoyager Therapeutics Inc
06/08/202420:01GlobeNewswire Inc.Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating ResultsNASDAQ:VYGRVoyager Therapeutics Inc
06/08/202420:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
30/07/202411:00GlobeNewswire Inc.Voyager Therapeutics Announces Second Quarter 2024 Conference Call and WebcastNASDAQ:VYGRVoyager Therapeutics Inc
23/07/202420:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
09/07/202420:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
09/07/202420:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
09/07/202420:01GlobeNewswire Inc.Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VYGRVoyager Therapeutics Inc
13/06/202420:01GlobeNewswire Inc.Voyager Therapeutics to Present at Multiple Virtual Investor ConferencesNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202411:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYGRVoyager Therapeutics Inc
13/06/202411:00GlobeNewswire Inc.Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial OfficerNASDAQ:VYGRVoyager Therapeutics Inc
07/06/202420:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/06/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/06/202420:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/06/202420:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
07/06/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYGRVoyager Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYGR

Your Recent History

BIT
SMCX
ETF
BOV
HALI34
Halliburton
BIT
WSAC25
Saccheria Flli Francesch...
BOV
ORCL34Q
Oracle
EU
DGRA
WisdomTree Issuer ICAV
TG
E1P0
Envipco Hldgs NV
BIT
P1HKZ2
BNP Paribas Issuance BV
BIT
P1KOC7
BNP Paribas Issuance
BIT
P1DBE5
BNP Paribas Issuance
BIT
P14Y59
BNP Paribas Issuance
AMEX
DMYY.U
dmy Squared Technology
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06